282 related articles for article (PubMed ID: 17255143)
41. Which antimicrobial impregnated central venous catheter should we use? Modeling the costs and outcomes of antimicrobial catheter use.
Marciante KD; Veenstra DL; Lipsky BA; Saint S
Am J Infect Control; 2003 Feb; 31(1):1-8. PubMed ID: 12548250
[TBL] [Abstract][Full Text] [Related]
42. Antimicrobial-impregnated central venous catheters for prevention of neonatal bloodstream infection (PREVAIL): an open-label, parallel-group, pragmatic, randomised controlled trial.
Gilbert R; Brown M; Rainford N; Donohue C; Fraser C; Sinha A; Dorling J; Gray J; McGuire W; Gamble C; Oddie SJ;
Lancet Child Adolesc Health; 2019 Jun; 3(6):381-390. PubMed ID: 31040096
[TBL] [Abstract][Full Text] [Related]
43. Chlorhexidine-impregnated dressing for the prophylaxis of central venous catheter-related complications: a systematic review and meta-analysis.
Wei L; Li Y; Li X; Bian L; Wen Z; Li M
BMC Infect Dis; 2019 May; 19(1):429. PubMed ID: 31096918
[TBL] [Abstract][Full Text] [Related]
44. Anti-adherence activity and antimicrobial durability of anti-infective-coated catheters against multidrug-resistant bacteria.
Raad I; Reitzel R; Jiang Y; Chemaly RF; Dvorak T; Hachem R
J Antimicrob Chemother; 2008 Oct; 62(4):746-50. PubMed ID: 18653489
[TBL] [Abstract][Full Text] [Related]
45. Anti-infective-treated central venous catheters for total parenteral nutrition or chemotherapy: a systematic review.
Niël-Weise BS; Stijnen T; van den Broek PJ
J Hosp Infect; 2008 Jun; 69(2):114-23. PubMed ID: 18439717
[TBL] [Abstract][Full Text] [Related]
46. CATheter Infections in CHildren (CATCH): a randomised controlled trial and economic evaluation comparing impregnated and standard central venous catheters in children.
Harron K; Mok Q; Dwan K; Ridyard CH; Moitt T; Millar M; Ramnarayan P; Tibby SM; Muller-Pebody B; Hughes DA; Gamble C; Gilbert RE
Health Technol Assess; 2016 Mar; 20(18):vii-xxviii, 1-219. PubMed ID: 26935961
[TBL] [Abstract][Full Text] [Related]
47. Observational trial of antibiotic-coated central venous catheters in critically ill pediatric patients.
Chelliah A; Heydon KH; Zaoutis TE; Rettig SL; Dominguez TE; Lin R; Patil S; Feudtner C; St John KH; Bell LM; Coffin SE
Pediatr Infect Dis J; 2007 Sep; 26(9):816-20. PubMed ID: 17721377
[TBL] [Abstract][Full Text] [Related]
48. Five-Lumen Antibiotic-Impregnated Femoral Central Venous Catheters in Severely Burned Patients: An Investigation of Device Utility and Catheter-Related Bloodstream Infection Rates.
Friedman BC; Mian MA; Mullins RF; Hassan Z; Shaver JR; Johnston KK
J Burn Care Res; 2015; 36(4):493-9. PubMed ID: 25407386
[TBL] [Abstract][Full Text] [Related]
49. In vitro exposure of bacteria to antimicrobial impregnated-central venous catheters does not directly lead to the emergence of antimicrobial resistance.
Munson EL; Heard SO; Doern GV
Chest; 2004 Nov; 126(5):1628-35. PubMed ID: 15539737
[TBL] [Abstract][Full Text] [Related]
50. Hospital-wide surveillance of catheter-related bloodstream infection: from the expected to the unexpected.
Zingg W; Sax H; Inan C; Cartier V; Diby M; Clergue F; Pittet D; Walder B
J Hosp Infect; 2009 Sep; 73(1):41-6. PubMed ID: 19646788
[TBL] [Abstract][Full Text] [Related]
51. Are antimicrobial-impregnated catheters effective? Don't throw out the baby with the bathwater.
Crnich CJ; Maki DG
Clin Infect Dis; 2004 May; 38(9):1287-92. PubMed ID: 15127342
[TBL] [Abstract][Full Text] [Related]
52. Chlorhexidine-silver sulfadiazine-impregnated venous catheters save costs.
Lorente L; Lecuona M; Jiménez A; Santacreu R; Raja L; Gonzalez O; Mora ML
Am J Infect Control; 2014 Mar; 42(3):321-4. PubMed ID: 24581021
[TBL] [Abstract][Full Text] [Related]
53. Effectiveness of antimicrobial-coated central venous catheters for preventing catheter-related blood-stream infections with the implementation of bundles: a systematic review and network meta-analysis.
Wang H; Tong H; Liu H; Wang Y; Wang R; Gao H; Yu P; Lv Y; Chen S; Wang G; Liu M; Li Y; Yu K; Wang C
Ann Intensive Care; 2018 Jun; 8(1):71. PubMed ID: 29904809
[TBL] [Abstract][Full Text] [Related]
54. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis.
Veenstra DL; Saint S; Saha S; Lumley T; Sullivan SD
JAMA; 1999 Jan; 281(3):261-7. PubMed ID: 9918482
[TBL] [Abstract][Full Text] [Related]
55. Selection of the vascular catheter: can it minimise the risk of infection?
Bouza E; Guembe M; Muñoz P
Int J Antimicrob Agents; 2010 Dec; 36 Suppl 2():S22-5. PubMed ID: 21130605
[TBL] [Abstract][Full Text] [Related]
56. Chlorhexidine-silver sulfadiazine-impregnated central venous catheters: in vitro antibacterial activity and impact on bacterial adhesion.
Monzillo V; Corona S; Lanzarini P; Dalla Valle C; Marone P
New Microbiol; 2012 Apr; 35(2):175-82. PubMed ID: 22707130
[TBL] [Abstract][Full Text] [Related]
57. Antimicrobial-impregnated central venous catheters.
Paterson DL
N Engl J Med; 1999 Jun; 340(22):1761; author reply 1762. PubMed ID: 10357631
[No Abstract] [Full Text] [Related]
58. Comparison of microbial adherence to antiseptic and antibiotic central venous catheters using a novel agar subcutaneous infection model.
Gaonkar TA; Modak SM
J Antimicrob Chemother; 2003 Sep; 52(3):389-96. PubMed ID: 12917250
[TBL] [Abstract][Full Text] [Related]
59. Comparison of silver-impregnated with standard multi-lumen central venous catheters in critically ill patients.
Kalfon P; de Vaumas C; Samba D; Boulet E; Lefrant JY; Eyraud D; Lherm T; Santoli F; Naija W; Riou B
Crit Care Med; 2007 Apr; 35(4):1032-9. PubMed ID: 17334256
[TBL] [Abstract][Full Text] [Related]
60. Catheter colonization in acute renal failure patients: comparison of central venous and dialysis catheters.
Souweine B; Liotier J; Heng AE; Isnard M; Ackoundou-N'Guessan C; Deteix P; Traoré O
Am J Kidney Dis; 2006 May; 47(5):879-87. PubMed ID: 16632028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
